Back to content Performance in 2021 The year 2021 was a very good year for the Demant Group, where we have achieved excellent results. Despite starting the year with high ambitions, we increased our profit expectations for the year three times ending with a record-high EBIT of DKK 3.4 billion and an EBIT margin of 18.4%. This was driven by organic sales growth of 27% for the year. Our hearing healthcare segment performed espe- cially well throughout the year, benefitting from new product introductions, a healthcare reform in France and some pent-up demand being released. On the cost side, we gained tempo- rary savings in the first half year. Purpose Life-changing hearing health H1 DKK 9,012 MILLION (48% growth) H2 DKK 9,406 MILLION (12% growth) 18,418 DKK MILLION (27% GROWTH) FY 2021 Listed on Nasdaq Copenhagen as part of the bluechip index, C25 Demant ∙ Sustainability Report 2021 20
Download PDF file